A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer
Clinical trial NCT05945901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05945901
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2025-12-01
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.